AGL News

Baird Maintains Neutral on Agilon Health, Lowers Price Target to $5

AGL

April 15, 2025
Read more →

These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio?

AGL

Top mid-cap stock performers last week: AGL, RXRX, CERT, AVAV, STRL, ORLA, IAG, SBSW, LOAR, RYTM, TLX. High gains due to positive news and macro uncertainty.

April 13, 2025
Read more →

12 Health Care Stocks Moving In Tuesday's Intraday Session

AGL

April 8, 2025
Read more →

Bernstein Upgrades Agilon Health to Outperform, Raises Price Target to $8.5

AGL

April 8, 2025
Read more →

Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Care

AGL

CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.

April 8, 2025
Read more →

12 Health Care Stocks Moving In Monday's After-Market Session

AGL

April 7, 2025
Read more →

Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals

AGL

JP Morgan analyst updates estimates for Agilon Health, Inc. based on Q4 results and management's outlook for recovery and growth in 2025-2027.

March 18, 2025
Read more →

CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday

AGL

February 26, 2025
Read more →

RBC Capital Maintains Outperform on Agilon Health, Raises Price Target to $3.5

AGL

February 26, 2025
Read more →

Citizens Capital Markets Reiterates Market Perform on Agilon Healthto Market Perform

AGL

February 26, 2025
Read more →

Stifel Maintains Hold on Agilon Health, Raises Price Target to $3

AGL

February 26, 2025
Read more →

4 Analysts Have This To Say About Agilon Health

AGL

February 26, 2025
Read more →

Needham Reiterates Hold on Agilon Healthto Hold

AGL

February 26, 2025
Read more →

Agilon Health Q4 2024 Adj EPS $(0.26) Misses $(0.23) Estimate, Sales $1.52B Inline

AGL

February 25, 2025
Read more →

Bernstein Maintains Market Perform on Agilon Health, Raises Price Target to $3.15

AGL

January 15, 2025
Read more →

Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday

AGL

January 13, 2025
Read more →

Citigroup Upgrades Agilon Health to Neutral, Raises Price Target to $2.25

AGL

January 10, 2025
Read more →

RBC Capital Reiterates Outperform on Agilon Health, Maintains $3 Price Target

AGL

November 19, 2024
Read more →

Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022

AGL

Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low of $2.89. Moreover, at the end of the last trading period, the closing price was at $4.26.

September 14, 2022
Read more →

RBC Capital Initiates Coverage On Agilon Health with Outperform Rating, Announces Price Target of $33

AGL

September 14, 2022
Read more →

Where Agilon Health Stands With Analysts

AGL

Within the last quarter, Agilon Health (NYSE:AGL) has observed the following analyst ratings:

September 12, 2022
Read more →

4 Analysts Have This to Say About Agilon Health

AGL

Analysts have provided the following ratings for Agilon Health (NYSE:AGL) within the last quarter:

September 12, 2022
Read more →

Analyst Ratings for Agilon Health

AGL

Analysts have provided the following ratings for Agilon Health (NYSE:AGL) within the last quarter:

September 12, 2022
Read more →

Goldman Sachs Initiates Coverage On Agilon Health with Buy Rating, Announces Price Target of $38

AGL

September 12, 2022
Read more →